The Drug Enforcement Agency, Last Acts Partnership, and the Pain & Policy Studies Group at the University of Wisconsin have issued a guidance document to address clinical and regulatory issues involving the prescription of controlled substances to treat pain.
The Drug Enforcement Agency, Last Acts Partnership, and the Pain & Policy Studies Group at the University of Wisconsin have issued a guidance document to address clinical and regulatory issues involving the prescription of controlled substances to treat pain.
The guidance contains frequently asked questions and answers for health care providers and law enforcement officials. It is a follow-up to a consensus statement on "Promoting Pain Relief and Preventing Abuse of Pain Medications: A Critical Balancing Act," issued by the three groups in 2001.
For more information, visit www.deadiversion.usdoj.gov/faq.
From evidence to practice: Dr. Makarov discusses implementation science in urology
July 25th 2024“What our major contribution is, I think as urologists doing implementation science, is determining the important questions, which we are particularly well-suited to do because we're taking care of the patients,” says Danil V. Makarov, MD, MHS.